Dr. Choueiri on Results of the SAVOIR Trial in MET-Driven Papillary RCC OncLive 2:46 4 years ago 128 Далее Скачать
Researcher comment: The SAVOIR trial | Toni Choueiri Medicine Matters oncology 4:24 4 years ago 85 Далее Скачать
Dr. Choueiri on Savolitinib in Papillary Renal Cell Cancer OncLive 2:03 7 years ago 414 Далее Скачать
Dr Toni Choueiri discusses a Phase 2 clinical trial on volitinib in papillary renal cell carcinoma EMJ 6:13 10 years ago 428 Далее Скачать
Dr. Choueiri on Impact of CABOSUN Results in Renal Cell Carcinoma OncLive 0:52 7 years ago 237 Далее Скачать
Dr. Toni Choueiri on Cabozantinib Versus Everolimus in Renal Cell Carcinoma OncLive 1:35 9 years ago 418 Далее Скачать
Dr. Choueiri on the Impact of the COVID-19 Pandemic on Treatment in RCC OncLive 0:59 4 years ago 80 Далее Скачать
Savolitinib plus durvalumab show promise in papillary renal cancer: CALYPSO results VJOncology 2:16 5 years ago 153 Далее Скачать
ESMO 2016: Press brief on results of CABOSUN trial cabozantinib compared to sunitinib in RCC VJOncology 6:26 8 years ago 486 Далее Скачать
Researcher comment: The FRACTION-RCC study | Toni Choueiri Medicine Matters oncology 3:12 4 years ago 174 Далее Скачать
PAPMET: MET inhibitors in treating papillary renal cell carcinoma VJOncology 2:35 3 years ago 880 Далее Скачать
Dr. Choueiri on Trials Investigating Combination Regimens for RCC OncLive 1:21 7 years ago 103 Далее Скачать
Results of a Trial Comparing Cabozantinib and Sunitinib in mRCC Targeted Oncology 2:12 8 years ago 107 Далее Скачать
